- Investing Ideas
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
205
Companies with a Value score of at least 3, ordered by Value score
205 companies
IQVIA Holdings
Market Cap: US$29.9b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
0JDM
US$176.85
7D
4.9%
1Y
-4.8%
Merck KGaA
Market Cap: €49.2b
Operates as a science and technology company in Germany and internationally.
0O14
€113.95
7D
-9.5%
1Y
-18.7%
Bavarian Nordic
Market Cap: DKK 14.5b
Develops, manufactures, and supplies life-saving vaccines.
0DPB
DKK 187.55
7D
-4.7%
1Y
12.1%
Perrigo
Market Cap: US$1.6b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
0Y5E
US$11.28
7D
-18.7%
1Y
-60.5%
BioNTech
Market Cap: US$26.0b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
0A3M
US$100.56
7D
-7.8%
1Y
-9.9%
BioNTech
Market Cap: €25.6b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
22UAD
€87.80
7D
-5.6%
1Y
n/a
Evolus
Market Cap: US$735.7m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
0K16
US$14.58
7D
0%
1Y
23.7%
Viatris
Market Cap: US$16.9b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
0A5V
US$14.54
7D
-6.2%
1Y
54.3%
Sarepta Therapeutics
Market Cap: US$1.7b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.
0L35
US$16.43
7D
-3.0%
1Y
-84.6%
Verastem
Market Cap: US$510.3m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
0LOV
US$6.15
7D
9.6%
1Y
-11.4%
Vitrolife
Market Cap: SEK 12.7b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
0YAY
SEK 92.88
7D
0.4%
1Y
-46.5%
Pharming Group
Market Cap: €925.6m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
0QCO
€1.37
7D
-1.7%
1Y
76.8%
GSK
Market Cap: UK£83.2b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£20.76
7D
-4.2%
1Y
38.4%
Beximco Pharmaceuticals
Market Cap: UK£51.2b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXP
UK£0.42
7D
0%
1Y
10.4%
Sanofi
Market Cap: €93.9b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SANP
€77.56
7D
-4.2%
1Y
-28.7%
Oxford Biomedica
Market Cap: UK£771.2m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£6.38
7D
2.7%
1Y
111.6%
HUTCHMED (China)
Market Cap: UK£1.7b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£2.02
7D
-8.2%
1Y
-18.5%
Geron
Market Cap: US$941.6m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
0IV3
US$1.43
7D
-9.5%
1Y
-15.4%
GSK
Market Cap: UK£83.2b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKL
UK£20.77
7D
-4.2%
1Y
38.1%
Sanofi
Market Cap: €93.9b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
0O59
€79.63
7D
-1.5%
1Y
-26.9%
PolyPeptide Group
Market Cap: CHF 819.8m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGNZ
CHF 24.95
7D
0%
1Y
21.0%
Agilent Technologies
Market Cap: US$34.1b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
0HAV
US$118.39
7D
0.02%
1Y
-7.2%
Amicus Therapeutics
Market Cap: US$4.5b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
0HF9
US$14.33
7D
-0.06%
1Y
58.1%
Ultragenyx Pharmaceutical
Market Cap: US$2.1b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
0LIF
US$21.67
7D
-4.6%
1Y
-45.7%
Novo Nordisk
Market Cap: DKK 1.1t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
0QIU
DKK 247.80
7D
3.7%
1Y
-59.3%
Zoetis
Market Cap: US$53.2b
Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
0M3Q
US$123.32
7D
-4.7%
1Y
-25.4%
Bayer
Market Cap: €37.2b
Operates as a life science company worldwide.
0P6S
€37.66
7D
-10.1%
1Y
52.5%
Hikma Pharmaceuticals
Market Cap: UK£2.7b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£12.10
7D
-11.9%
1Y
-44.1%
Photocure
Market Cap: NOK 1.8b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
0IMT
NOK 70.50
7D
20.3%
1Y
38.9%
H. Lundbeck
Market Cap: DKK 37.2b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
0ABR
DKK 34.20
7D
-2.3%
1Y
7.0%
Dermapharm Holding
Market Cap: €2.1b
Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
0A5J
€38.13
7D
-3.4%
1Y
-2.2%
Novavax
Market Cap: US$1.6b
A biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.
0A3S
US$9.94
7D
-13.3%
1Y
29.9%
Merck KGaA
Market Cap: €53.5b
Operates as a science and technology company in Germany and internationally.
MRKD
€128.60
7D
2.2%
1Y
-5.9%
Evotec
Market Cap: €968.9m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
0IRF
€5.56
7D
-3.8%
1Y
-21.6%
Diaceutics
Market Cap: UK£124.0m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.46
7D
-3.0%
1Y
6.6%
Cellectis
Market Cap: €239.4m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
0WA2
€3.36
7D
-1.5%
1Y
171.4%